ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements with these filters
Shukra Pharmaceuticals Ltd issued a corrigendum to its Postal Ballot notice regarding the proposed alteration of its Main Object Clause and name change.
Shukra Pharmaceuticals has scheduled its 33rd Annual General Meeting on September 28, 2026, to be held via Video Conferencing.
Shukra Pharmaceuticals has issued a postal ballot notice seeking shareholder approval for an amendment to its Memorandum of Association's Object Clause.
Shukra Pharmaceuticals held an EOGM on July 6, 2026 via video conference. The meeting approved the issuance of 4,643,000 convertible equity warrants to promoters.
Shukra Pharmaceuticals has called an EGM on July 6, 2026 to seek fresh approval for a preferential warrant issue. The move ensures compliance with SEBI ICDR regulations after a prior allotment delay.